Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms, Male 2Breast Neoplasms 2Melanoma 1

Interventions

Trastuzumab 243Paclitaxel 193Cyclophosphamide 158Docetaxel 134Letrozole 113Capecitabine 113Fulvestrant 106Doxorubicin 103Bevacizumab 87Carboplatin 81exemestane 80Anastrozole 79Lapatinib 70Tamoxifen 69Albumin-Bound Paclitaxel 57palbociclib 54pertuzumab 53Taxes 51Gemcitabine 50Radiotherapy 46eribulin 43pembrolizumab 41Everolimus 41Ado-Trastuzumab Emtansine 41Vinorelbine 38130-nm albumin-bound paclitaxel 35ixabepilone 32Epirubicin 28pegfilgrastim 25liposomal doxorubicin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Breast Neoplasms × saponin QA-21V1 × Clear all
NCT00470574 2020-11-18

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Completed
7 enrolled 7 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00030823 2015-12-30

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

Memorial Sloan Kettering Cancer Center

Phase NA Completed
14 enrolled 6 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡